Two current and two former senior AstraZeneca Plc executives in the group’s China unit are under investigation in a probe into alleged breaches of laws around drug importation and data privacy, the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Dakota Wealth Management cut its stake in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 1.8% in the 3rd quarter, ...

AstraZeneca may be emphasizing the potential for combination treatments to help its obesity pipeline stand out from the crowd, but the Big Pharma insists it is still “playing to win” in the space.

AstraZeneca Plc said its experimental obesity pill was well tolerated by patients with type-2 diabetes as it presented data from several studies testing its three new weight-loss medicines. The ...

Leon Wang, EVP international and AstraZeneca China President, is cooperating with an ongoing investigation by Chinese ...

The U.K. pharmaceutical company AstraZeneca has become the largest multinational drugmaker in China, drawing 13% of its $5.8 billion in revenue last year from there, against a backdrop of an acute ...

BALTIMORE - Abortion rights are front and center on the 2024 Maryland election ballot with Question 1. Abortion is legal in Maryland. However, state lawmakers last year passed an amendment that ...

BEIJING—An investigation involving a top executive at drugmaker AstraZeneca AZN-1.36%decrease; red down pointing triangle is the latest to rattle foreign companies in China, where a series of ...

Louis Aronne, MD, a professor of metabolic research at Weill Cornell Medicine in New York City ... Jastreboff reported ...

As AstraZeneca’s chronic obstructive pulmonary disease drug Breztri continues climbing toward blockbuster status, the Big Pharma is broadening its efforts to support people with COPD.

ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca.